Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NanoString Technologies, Inc. - Common Stock (NQ: NSTG )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NanoString Technologies, Inc. - Common Stock

< Previous 1 2 3 4 Next >
NanoString Announces Completion of Financing to Support Restructuring Process
From NanoString Technologies, Inc.
Via Business Wire
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
From NanoString Technologies, Inc.
Via Business Wire
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
From NanoString Technologies, Inc.
Via Business Wire
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
From NanoString Technologies, Inc.
Via Business Wire
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
From NanoString Technologies, Inc.
Via Business Wire
NanoString Comments on Delaware District Court Verdict
From NanoString Technologies, Inc.
Via Business Wire
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
From NanoString Technologies, Inc.
Via Business Wire
NanoString Technologies Releases Operating Results for Third Quarter of 2023
From NanoString Technologies, Inc.
Via Business Wire
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
From NanoString Technologies, Inc.
Via Business Wire
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
From NanoString Technologies, Inc.
Via Business Wire
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
From NanoString Technologies, Inc.
Via Business Wire
NanoString Comments on Unified Patent Court Order
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Host Virtual Spatial Genomics Summit September 19
From NanoString Technologies, Inc.
Via Business Wire
NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered
From NanoString Technologies, Inc.
Via Business Wire
NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
From NanoString Technologies, Inc.
Via Business Wire
NanoString Appoints Todd Garland as Chief Commercial Officer
From NanoString Technologies, Inc.
Via Business Wire
NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
From NanoString Technologies, Inc.
Via Business Wire
NanoString Technologies Releases Operating Results for Second Quarter of 2023
From NanoString Technologies, Inc.
Via Business Wire
Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
From NanoString Technologies, Inc.
Via Business Wire
Helen of Troy and NanoString Technologies Trade Set-ups
Helen of Troy and NanoString Technologies emerge as hot trades after beating expectations and giving solid guidance for the year. 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023
From NanoString Technologies, Inc.
Via Business Wire
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
From NanoString Technologies, Inc.
Via Business Wire
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
From NanoString Technologies, Inc.
Via Business Wire
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
From NanoString
Via Business Wire
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
From NanoString Technologies, Inc.
Via Business Wire
NanoString to Webcast Presentation from Jefferies Healthcare Conference
From NanoString Technologies, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.